1. Home
  2. AURA vs KELYA Comparison

AURA vs KELYA Comparison

Compare AURA & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • KELYA
  • Stock Information
  • Founded
  • AURA 2007
  • KELYA 1946
  • Country
  • AURA United States
  • KELYA United States
  • Employees
  • AURA N/A
  • KELYA N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • KELYA Professional Services
  • Sector
  • AURA Health Care
  • KELYA Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • KELYA Nasdaq
  • Market Cap
  • AURA 396.8M
  • KELYA 438.6M
  • IPO Year
  • AURA 2021
  • KELYA N/A
  • Fundamental
  • Price
  • AURA $6.01
  • KELYA $12.89
  • Analyst Decision
  • AURA Strong Buy
  • KELYA Buy
  • Analyst Count
  • AURA 7
  • KELYA 1
  • Target Price
  • AURA $22.29
  • KELYA $25.00
  • AVG Volume (30 Days)
  • AURA 283.0K
  • KELYA 310.6K
  • Earning Date
  • AURA 11-11-2025
  • KELYA 11-06-2025
  • Dividend Yield
  • AURA N/A
  • KELYA 2.32%
  • EPS Growth
  • AURA N/A
  • KELYA N/A
  • EPS
  • AURA N/A
  • KELYA N/A
  • Revenue
  • AURA N/A
  • KELYA $4,495,900,000.00
  • Revenue This Year
  • AURA N/A
  • KELYA $4.55
  • Revenue Next Year
  • AURA N/A
  • KELYA $5.01
  • P/E Ratio
  • AURA N/A
  • KELYA N/A
  • Revenue Growth
  • AURA N/A
  • KELYA 0.97
  • 52 Week Low
  • AURA $4.35
  • KELYA $10.80
  • 52 Week High
  • AURA $12.38
  • KELYA $22.44
  • Technical
  • Relative Strength Index (RSI)
  • AURA 35.91
  • KELYA 41.18
  • Support Level
  • AURA $5.93
  • KELYA $12.74
  • Resistance Level
  • AURA $6.28
  • KELYA $13.22
  • Average True Range (ATR)
  • AURA 0.25
  • KELYA 0.37
  • MACD
  • AURA -0.03
  • KELYA -0.07
  • Stochastic Oscillator
  • AURA 0.00
  • KELYA 12.58

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: